Jiangsu Hualan New Pharmaceutical Material (301093.SZ): The joint evaluation and approval result of the aluminum cap and formulation for pen-type injectors has been upgraded to "A" status.

date
16:38 06/11/2025
avatar
GMT Eight
Hualan Shares (301093.SZ) announced that the aluminum cap for the company's pen-type injector has recently passed the national drug supervision and administration...
Jiangsu Hualan New Pharmaceutical Material (301093.SZ) announced that the aluminum cap for the company's prefilled syringe recently passed the technical review by the Drug Evaluation Center of the National Medical Products Administration (referred to as "CDE"). It has been shown on the CDE registration information public platform for raw materials, pharmaceutical excipients, and pharmaceutical packaging materials that the status has been changed from "joint review and approval results with formulations" to "A" status.